Computer laptop with a TSX logo on the screen
(File photo)

Continued pressure from the heavyweight financial and energy sectors dragged Canada’s main stock index lower for a third consecutive session. Minor tech, mining and healthcare gains mitigated some losses for the TSX. Statistics Canada reported that retail sales decreased 0.8 per cent to C$66.1 billion in May. Sales were down in eight of nine subsectors, led by a drop among food and beverage retailers.

South of the border, the broad sell-off continued as the main indices also continued their downward trend that began earlier this week. This was exacerbated by the global technology outage that caused a big drop in CrowdStrike stock and a slight dip in Microsoft’s stock.

TSX22,690.39-36.37TSX
TSXV580.08+1.24TSXV
CSE167.42-4.27CSE
DJIA40,287.53-377.49DJIA
NASDAQ17,726.94-144.28NASDAQ
S&P 5005,503.50-41.09S&P 500

The Canadian dollar traded for 72.82 cents U.S. compared with 72.91 cents U.S. on Thursday.

U.S. crude futures traded $2.53 lower at $80.20 a barrel, and the Brent contract lost $2.35 to $82.76 a barrel.

The price of gold was down US$43.61 to US$2,398.22.

In world markets, the Nikkei was down 62.56 points to 40,063.79, the Hang Seng was down 360.73 points to 17,417.68, the FTSE was down 49.17 points to 8,155.72, and the DAX was down 189.17 points to 18,165.59.


The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.

(Top image: File)


More From The Market Online
Air Canada airliner

Air Canada negotiates new labour deal with pilots, avoids shutdown

Air Canada (TSX:AC) and the union representing thousands of its pilots negotiated a new labour deal and averted a nationwide shutdown.
Tudor Gold 2020 drilling at Treaty Creek.

Tudor Gold to advance Treaty Creek Project with Fuse Advisors

Tudor Gold (TSXV:TUD) enters into an agreement with Fuse Advisors to advance the Treaty Creek Project in British Columbia's Golden Triangle.
U.S. Food and Drug website in browser with logo

FDA extends review period for Medexus’ treosulfan to 2025

Medexus Pharmaceuticals (TSX:MDP) reveals the U.S. FDA has extended the review period for the company's new drug application for treosulfan.
King's Cross station in London

AtkinsRéalis boosts long-term revenue with U.K. rail contract

AtkinsRéalis Group (TSX:ATRL) will modernize the U.K.'s rail signalling infrastructure over the next decade.